Vaxcyte, Inc.
PCVX • NASDAQ
Vaxcyte, Inc. is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Grant E. Pickering, with a market cap of $7.7B.
CEOGrant E. Pickering
Next Earnings
Upcoming earnings announcement for Vaxcyte, Inc.
Date
Wednesday, May 6, 2026 (in a month)
Timing
After Market Close (4:00 PM New York)
Fiscal Period
Q1 2026
EPS Estimate
-$1.81
Revenue Estimate
$12.5M
Earnings History
Past 12 earnings reports for Vaxcyte, Inc.
| Date | Period | EPS | EPS Surprise | Revenue | Rev. Surprise | Filing |
|---|---|---|---|---|---|---|
| Feb 24, 2026 | Q4 2025 | -$1.80Est: -$1.49 | -20.8% | - | — |  10-K |
| Nov 4, 2025 | Q3 2025 | -$1.56Est: -$1.25 | -24.8% | - | — | 10-Q |
| Aug 6, 2025 | Q2 2025 | -$1.22Est: -$1.15 | -6.1% | - | — | 10-Q |
| May 7, 2025 | Q1 2025 | -$1.04Est: -$0.92 | -13.0% | - | — | 10-Q |
| Feb 25, 2025 | Q4 2024 | -$1.02Est: -$1.14 | +10.5% | - | — | 10-K |
| Nov 5, 2024 | Q3 2024 | -$0.83Est: -$1.11 | +25.2% | - | — | 10-Q |
| Aug 6, 2024 | Q2 2024 | -$1.10Est: -$0.98 | -12.2% | - | — | 10-Q |
| May 8, 2024 | Q1 2024 | -$0.85Est: -$1.09 | +22.0% | - | — | 10-Q |
| Feb 27, 2024 | Q4 2023 | -$1.82Est: -$1.07 | -70.1% | - | — | 10-K |
| Nov 6, 2023 | Q3 2023 | -$0.91Est: -$0.84 | -8.3% | - | — | — |
| Aug 8, 2023 | Q2 2023 | -$0.70Est: -$0.74 | +5.4% | - | — | 10-Q |
| May 8, 2023 | Q1 2023 | -$0.70Est: -$0.83 | +15.7% | - | — | — |